Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

NP10679

TargetMol
NP10679
NP10679 is an orally available, selective, brain-penetrating, potent, and pH-sensitive N-methyl-D-aspartate (NMDA) receptor inhibitor of the GluN2B subunit.NP10679 inhibits histamine H1, hERG channels, and CYP enzymes, and may be useful in the study of epilepsy and ischemic stroke.
Catalog No. T73447Cas No. 2914889-88-4
Select Batch
Purity:99.43%
ee:99.85%
Contact us for more batch information

NP10679

TargetMol
Catalog No. T73447Cas No. 2914889-88-4
NP10679 is an orally available, selective, brain-penetrating, potent, and pH-sensitive N-methyl-D-aspartate (NMDA) receptor inhibitor of the GluN2B subunit.NP10679 inhibits histamine H1, hERG channels, and CYP enzymes, and may be useful in the study of epilepsy and ischemic stroke.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$293In Stock
5 mg$722In Stock
10 mg$987In Stock
25 mg$1,520In Stock
50 mg$1,980In Stock
100 mg$2,500In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "NP10679"

Product Introduction

Bioactivity
Description
NP10679 is an orally available, selective, brain-penetrating, potent, and pH-sensitive N-methyl-D-aspartate (NMDA) receptor inhibitor of the GluN2B subunit.NP10679 inhibits histamine H1, hERG channels, and CYP enzymes, and may be useful in the study of epilepsy and ischemic stroke.
Targets&IC50
H1 Receptor:0.04 μM (Ki), α1B-adrenoceptor:1.92 μM (Ki), α2C-adrenoceptor:3.09 μM (Ki), α1A-adrenoceptor:0.154 μM, α1A-adrenoceptor:0.603 μM (Ki), H1 Receptor:0.073 μM, α1D-adrenoceptor:0.495 μM (Ki)
In vitro
NP10679 is an NMDA receptor inhibitor containing GluN2B that is more effective than physiological pH. It exhibits inhibitory effects on 5-HT2A, α1A adrenergic receptor, H1 histamine receptor, and hERG channels[2].
In vivo
In the Male C57BL/6 middle cerebral artery occlusion (MCAo) model of transient ischemia mice, NP10679 (2, 5, and 10 mg/kg; intraperitoneal injection; administered 15 minutes prior to transient ischemia) dose-dependently reduces infarct volumes, with an ED50 of 1 mg/kg[2].
Chemical Properties
Molecular Weight449.47
FormulaC23H26F3N3O3
Cas No.2914889-88-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (177.99 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2248 mL11.1242 mL22.2484 mL111.2421 mL
5 mM0.4450 mL2.2248 mL4.4497 mL22.2484 mL
10 mM0.2225 mL1.1124 mL2.2248 mL11.1242 mL
20 mM0.1112 mL0.5562 mL1.1124 mL5.5621 mL
50 mM0.0445 mL0.2225 mL0.4450 mL2.2248 mL
100 mM0.0222 mL0.1112 mL0.2225 mL1.1124 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy NP10679 | purchase NP10679 | NP10679 cost | order NP10679 | NP10679 chemical structure | NP10679 in vivo | NP10679 in vitro | NP10679 formula | NP10679 molecular weight